Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Jimmy K. Lee, MD, Director of the Cornea and Refractive Surgery Section, Yale Eye Center, discusses dry eye treatment, including lubricant drops, cyclosporin and plugging the drainage tube…
NEW YORK (Reuters Health) – Patients with early (stage I and IIA) colon cancer derive similar benefits from intensive postoperative surveillance as those with late stage IIB and…
NEW YORK (Reuters Health) – Combined positron-emission tomography and computed tomography (PET-CT) improves the staging of non-small cell lung cancer (NSCLC) and also reduces the numbers of total…
NEW YORK (Reuters Health) – High intake of saturated and monounsaturated fat may increase the risk of pancreatic cancer, according to a report in the Journal of the…
NEW YORK (Reuters Health) – New research suggests that for some patients with cancer, especially brain tumors and small-cell-lung cancer, the first manifestation is a psychiatric symptom. The…
NEW YORK (Reuters Health) – New research indicates that with effective chemotherapy, children with acute lymphoblastic leukemia (ALL) do not need to receive prophylactic cranial irradiation. Prophylactic cranial…
NEW YORK (Reuters Health) – In patients with unresectable pancreatic cancer, the combination of gemcitabine and a novel cationic liposomal formulation of paclitaxel called EndoTAG-1 substantially prolongs survival…
NEW YORK (Reuters Health) – In a phase III study of patients with progressive well-differentiated pancreatic islet cell tumors, treatment with the tyrosine kinase inhibitor sunitinib significantly prolonged…
NEW YORK (Reuters Health) – As the number of African Americans in a given US county increases, the number of specialists involved in colorectal cancer care decreases, according…
NEW YORK (Reuters Health) – Survivors of Hodgkin’s lymphoma are to 2- to 3-times more likely to experience a stroke or TIA compared with people in the general…
